Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 63253 dokumen yang sesuai dengan query
cover
Soedarsono
"Background: multidrug-resistant organisms (MDRO) caused pneumonia has become a crucial case. MDRO infection has been a problem concern to community-acquired pneumonia (CAP). A lot of factors play roles in CAP with MDRO infection. This study aimed to analyze MDRO as the etiology of hospitalized patients with CAP along with its risk factors in Dr. Soetomo Hospital as one of the top referral hospitals in east Indonesia. Methods: this retrospective cohort study was conducted from January 2016 to December 2018. Data were collected from patients' medical records. Automatic Rapid Diagnosis (Phoenix TM) was used as a standard method for culture and susceptibility test. Various risk factors were analyzed for MDRO infection. Results: five most common pathogens in hospitalized patients with CAP were Acinetobacter baumannii 244/1364 (17.9%), Klebsiella pneumoniae 134/1364 (9.8%), Pseudomonas aeruginosa 91/1364 (6.7%), Escherichia coli 58/1364 (4.3%), and Enterobacter cloacae 45/1364 (3.3%). There were 294/1364 (21.5%) MDROs isolated from patients with CAP. MDRO infection was linked to previous hospitalization, malignancy, cardiovascular disease, and structural lung disease with p values of 0.002, <0.001, 0.024, and <0.001, respectively. Conclusion: the incidence of MDRO in CAP is high (21.5%). The risk factors related were previous hospitalization, malignancy, cardiovascular disease, and structural lung disease."
Jakarta: University of Indonesia. Faculty of Medicine, 2021
610 UI-IJIM 53:2 (2021)
Artikel Jurnal  Universitas Indonesia Library
cover
Purba, Abdul Khairul Rizki
"[ABSTRAK
Latar belakang:
Penggunaan antibiotik empirik pada tata laksana penyakit infeksi, misalnya pneumonia
komunitas, sebaiknya mempertimbangkan bukti kemanfaatan klinis dan hasil
sensitivitas antibiotik pada suatu institusi pelayanan kesehatan. Penggunaan antibiotik
yang tidak tepat dapat menyebabkan kegagalan terapi, resistensi kuman, komplikasi
dan kematian. Biaya yang tinggi juga merupakan keluaran langsung dari penggunaan
antibiotik namun biasanya tidak dilaporkan. Oleh sebab itu, analisis terhadap biaya,
keluaran klinis, dan pola sensitivitas kuman menjadi sangat penting untuk menentukan
antibiotik empirik pada terapi pneumonia komunitas.
Tujuan:
Tujuan penelitian ini adalah menentukan antibiotik yang paling efektif dari aspek biaya
dan keluaran klinis pada tata laksana pneumonia komunitas.
Metode:
Penelitian ini dilakukan secara retrospektif pada pasien pneumonia komunitas di RSU
Dr. Soetomo Surabaya sejak 1 Januari sampai 31 Desember 2013. Analisis cost
effectiveness digunakan untuk evaluasi farmakoekonomi berdasarkan perbaikan klinis
hari ke-5, mortalitas, dan biaya total.
Hasil:
Sebanyak 434 pasien dirawat di RSU Dr. Soetomo dan menerima antibiotik empirik.
Sebanyak 200 pasien dikelompokkan menjadi 4 grup: seftriakson(35%), seftazidim
(26%), levofloksasin (14,5%), dan kombinasi seftazidim dan levofloksasin (24,5%).
Perbaikan klinis hari ke-5 tertinggi adalah kelompok yang diberi seftazidim sekitar
67,3%. Seftriakson merupakan antibiotik empirik yang paling efektif dengan ACER
505.585,3 untuk perbaikan klinis hari ke-5 namun hasil sensitivitas kuman
menunjukkan bahwa seftazidim masih lebih sensitif dari pada seftriakson (61,1% vs
38,5%) dengan nilai ACER seftazidim sebesar 763.322. Kombinasi seftazidim dan
levofloksasin digunakan untuk pasien dengan klinis yang buruk (PSI: 84,1+28,6) dan
berdampak pada tingginya biaya pengobatan (ACER 23685450.5).
Kesimpulan:
Seftazidim dapat dipertimbangkan sebagai antibiotik empirik yang efektif dan efisien
dalam tata laksana pneumonia komunitas yang dirawat di rumah sakit. Kombinasi seftazidim dan levofloksasin juga dapat dipertimbangkan untuk pasien pneumonia komunitas yang berat.ABSTRACT Introduction:
Empirical antibiotic use in the management of infectious disease such as community
pneumonia should be considered based on evidence of clinical effectiveness and
institutional antibiotic sensitivity results. Inappropriate antibiotic leads to failure in
treatment, microbial resistance, complications and mortality. In addition, high cost is
one of the direct impact of this condition that is usually under-reported. Thus, analysis
of cost and clinical outcome, besides antibiotic sensitivity pattern, should be performed
to find effective empirical antibiotic in the treatment in community acquired
pneumonia (CAP).
Aim:
The objective of the study was to determine the most effective antibiotic in cost and
clinical outcome in CAP.
Methodology:
This study has been conducted retrospectively in patient with CAP in Dr. Soetomo
Hospital Surabaya from 1 January to 31 December 2013. Cost effectiveness analysis
was used to evaluate pharmacoeconomic outcomes based on clinical improvement in
day 5, mortality, and total cost.
Results:
There were 434 hospitalized patients with pneumonia that received empirical
antibiotic. Two hundred patients were selected based on inclusion and exclusion
criteria of this study. Subjects were categorized into 4 groups: ceftriaxone (35%),
ceftazidim (26%), levofloxacin (14.5%), and combination ceftazidim and levofloxacin
(24.5%). Clinical improvement in day 5 and clinical remission was assessed with
highest number in ceftazidim group, roughly 67.3% and 76,9% respectively.
Furthermore, ceftriaxone was the most effective one with ACER 505585.3 for day 5
outcome. However, the ceftazidim sensitivity was higher than ceftriaxone (61,1% vs
38,5%), while ceftazidime was in the one second position with ACER 763322. The
combination ceftazidim and levofloxacin particularly used in worse clinical symptom
(PSI: 84,1+28,6) and lead to the highest cost with ACER 23685450.5.
Conclusion:
Ceftazidim should be considered as effective and efficient empirical antibiotic in the
management of hospitalized CAP. However, combination ceftazidim and levofloxacin is also could be effective to improve clinical sign for particular patient even with severe CAP. , Introduction:
Empirical antibiotic use in the management of infectious disease such as community
pneumonia should be considered based on evidence of clinical effectiveness and
institutional antibiotic sensitivity results. Inappropriate antibiotic leads to failure in
treatment, microbial resistance, complications and mortality. In addition, high cost is
one of the direct impact of this condition that is usually under-reported. Thus, analysis
of cost and clinical outcome, besides antibiotic sensitivity pattern, should be performed
to find effective empirical antibiotic in the treatment in community acquired
pneumonia (CAP).
Aim:
The objective of the study was to determine the most effective antibiotic in cost and
clinical outcome in CAP.
Methodology:
This study has been conducted retrospectively in patient with CAP in Dr. Soetomo
Hospital Surabaya from 1 January to 31 December 2013. Cost effectiveness analysis
was used to evaluate pharmacoeconomic outcomes based on clinical improvement in
day 5, mortality, and total cost.
Results:
There were 434 hospitalized patients with pneumonia that received empirical
antibiotic. Two hundred patients were selected based on inclusion and exclusion
criteria of this study. Subjects were categorized into 4 groups: ceftriaxone (35%),
ceftazidim (26%), levofloxacin (14.5%), and combination ceftazidim and levofloxacin
(24.5%). Clinical improvement in day 5 and clinical remission was assessed with
highest number in ceftazidim group, roughly 67.3% and 76,9% respectively.
Furthermore, ceftriaxone was the most effective one with ACER 505585.3 for day 5
outcome. However, the ceftazidim sensitivity was higher than ceftriaxone (61,1% vs
38,5%), while ceftazidime was in the one second position with ACER 763322. The
combination ceftazidim and levofloxacin particularly used in worse clinical symptom
(PSI: 84,1+28,6) and lead to the highest cost with ACER 23685450.5.
Conclusion:
Ceftazidim should be considered as effective and efficient empirical antibiotic in the
management of hospitalized CAP. However, combination ceftazidim and levofloxacin is also could be effective to improve clinical sign for particular patient even with severe CAP. ]"
Fakultas Kedokteran Universitas Indonesia, 2015
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Annisa Sutera Insani
"ABSTRAK
Metode : Penelitian ini menggunakan studi kasus kontrol berpasangan, dilakukan di ruang rawat inap RSUP Persahabatan pada bulan November 2018-Maret 2019. Kriteria kasus semua pasien yang terdiagnosis HAP saat perawatan, kriteria kontrol berpasangan adalah, jenis kelamin sama dengan kasus, usia ± 10 tahun dengan kasus dan dirawat di ruang perawatan yang sama dengan kasus. Pada kelompok kasus dan kontrol dilakukan pemeriksaan foto toraks untuk melihat infiltrat baru dibandingkan dengan foto lama. Pada kelompok kasus dilakukan pemeriksaan biakan sputum dan darah sebagai data pola mikroorganisme HAP.
Hasil : Didapatkan 25 kasus HAP dan faktor risiko HAP dinilai dari 23 pasang subjek penelitia. Faktor risiko intrinsik yang paling berperan pada HAP adalah hipoalbuminemia (OR 5 [IK 95% 3,34-6,63], p=0,039). Faktor ekstrinsik HAP yang paling berperan adalah penggunaan obat lambung dengan (p=0,016). Pola mikroorganisme pasien HAP dari 25 pasien HAP biakan yang tumbuh 19 (78,7% dahak dan 21,3% darah). Lima belas sampel (78,9%) adalah Gram negatif, dan 5 (26,3%) diantaranaya adalah Acinetobacter baumanii. Dari 19 mikroorganisme yang tumbuh terdapat 63,5% MDRO.
Kesimpulan: Hipoalbuminemia adalah faktor risiko yang paling berperan dalam terjadinya HAP serta mikroorganisme terbanyak adalah Acinetobacter baumanii.

ABSTRACT
Background: Hospital acquired pneumonia (HAP) is the second largest cause of nosocomial infections. The pneumonia occurs after 48 hours of inpatient admission in hospital. Risk factors affecting HAP consists of intrinsic and extrinsic factors. Early detection of risk factors would decrease morbidity and mortality in HAP case.
Objectives: This study was to identify risk factors that influence the occurrence of HAP infections and microbiological profile of HAP patients.
Methods: This matched-case control study involved patients treated at regular wards (e.g. not an intensive care ward) of National Respiratory Referral Hospital Persahabatan Jakarta, Indonesia between November 2018 and March 2019. The case and control group were matched for their sex, age (±10 yo), and length of hospital stay (±7 days). Both groups received chest x-ray (CXR) examination while the control group exclusively received sputum and blood culture for microbiology of HAP.
Results: This study involved 25 HAP patients and 23 matched-control patients. The main intrinsic risk factor for HAP was hypoalbuminemia (OR 5.00 [CI95% 3.34-6.63], p=0.039) and the main extrinsic risk factor for HAP was administration of gastric medications (p=0.016). Nineteen out of 25 microbiological samples were collected; of which, 78.7% were collected from sputum culture and 21.3% were collected from blood culture. Fifteen (78.9%) of those were positive for Gram-negative, 5 (26.3%) were positive for Acinetobacter baumanii, and 12 (63.5%) were positive for multi-drug resistance organism."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2019
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Artati Murwaningrum
"Latar Belakang: Infeksi HAP oleh bakteri multidrug-resistant (MDR) menyebabkan mortalitas yang tinggi, lama rawat yang memanjang dan biaya perawatan yang tinggi. Karena itu perlu diketahui gambaran faktor risiko terjadinya infeksi bakteri MDR pada pasien HAP.
Tujuan: Mengetahui gambaran faktor risiko terjadinya infeksi bakteri MDR pada pasien HAP di RSUPN Cipto Mangunkusumo.
Metode: Penelitian dengan desain Kohort retrospektif menggunakan rekam medik pasien HAP yang memiliki hasil kultur sputum di RSUPN Cipto Mangunkusumo tahun 2015-2016 dengan metode total sampling. Pasien HAP diklasifikasikan menjadi terinfeksi bakteri MDR dan terinfeksi bakteri bukan MDR berdasarkan kategori resistensi isolat yang paling resisten pada sputum yang pertama kali didiagnosis MDR. Evaluasi gambaran faktor risiko dilakukan kepada semua subjek. Seluruh analisis dilakukan menggunakan program Microsoft Excel.
Hasil: Proporsi HAP selama tahun 2015 dan 2016 berturut-turut adalah 6,12 dan 6,15/1000 admisi. Proporsi pasien HAP yang terinfeksi bakteri MDR selama tahun 2015 dan 2016 berturut-turut adalah 95% dan 82,1%. Gambaran proporsi faktor risiko infeksi bakteri MDR pada pasien HAP RSUPN Cipto Mangunkusumo tahun 2015-2016 mulai dari yang paling tinggi ke yang paling rendah berturut-turut adalah riwayat pemakaian antibiotik 90 hari sebelum diagnosis (100%), albumin <2.5 g/dL (100%), Charlson Comorbidity index≥3 (95,9%), usia> 60 (95,2%), lama rawat> 5 hari (92,5%), riwayat pemasangan NGT (92,1%), riwayat perawatan ICU/HCU sebelumnya (81,8%) dan penggunaan steroid setara prednison>10 mg/hari atau ekivalen selama>14 hari (28,6%).
Simpulan: Proporsi infeksi bakteri MDR pada pasien HAP RSUPN Cipto Mangunkusumo tahun 2015 dan 2016 berturut-turut adalah 95% dan 82,1% dengan proporsi faktor risiko infeksi bakteri MDR yang paling tinggi adalah pada pasien dengan riwayat pemakaian antibiotik 90 hari sebelum diagnosis dan albumin <2.5 g/dL.
>
Background: Multi-drug Resistant (MDR) Hospital-acquired Pneumonia (HAP) is associated with high mortality, prolonged hospital stay and high cost. Therefore, it is important to have description risk factors distribution for MDR HAP.
Aim: To have description of risk factors proportion for infection with MDR bacteria in HAP patients hospitalized in Cipto Mangunkusumo General Hospital.
Methods: A Cohort retrospective study with total sampling methode was conducted to collect medical records of HAP patients hospitalized in 2015-2016. Patients were classified as infected with MDR bacteria and infected with non-MDR bacteria based on the most resistant category of the sputum firstly diagnosed infected with multidrug-resistant bacteria. Risk factors evaluation were conducted to all subjects. All analysis was done using Microsoft Excel.
Results: Proportion of HAP during 2015 and 2016 respectively were 6.12 per 1000 admission and 6.15 per 1000 admission. Proportion of HAP patients infected with MDR bacteria in 2015 and 2016 were 95% and 82,1% respectively. MDR bacteria in 2015 and 2016 were 95% and 82,1% respectively. Description of risk factors proportion for infection with MDR bacteria from the highest to lowest respectively were prior antibiotic use 90 days before diagnosis (100%), albumin level <2.5 g/dL (100%), Charlson Comorbidity index≥3 (95,9%), age >60 years (95,2%), hospitalization>5 days (92,5%), NGT insertion (92,1%), prior ICU/HCU hospitalization in the last 90 days (81,8%) and prior steroid use equivalent to prednisone >10 mg/day for >14 days (28,6%).
Conclusion: Proportion of HAP patients infected with MDR bacteria in 2015 and 2016 were 95% and 82,1% respectively with the highest risk factors proportion for infection with multidrug-resistant bacteria were prior antibiotic use in 90 days before diagnosis and albumin <2,5 g/dL."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2018
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Mohammad Adi Firmansyah
"Latar Belakang: Pneumonia komunitas masih merupakan salah satu penyebab kematian terbanyak untuk penyakit infeksi, baik di negara maju ataupun negara berkembang. Pengetahuan tentang prediktor mortalitas dapat membantu pengambilan keputusan klinis untuk tatalaksana pasien. Penelitian terdahulu mengenai prediktor mortalitas di luar negeri sebagian besar dilakukan pada usia lanjut dan hanya ditemukan satu penelitian mengenai faktor-faktor prediktor mortalitas di Indonesia namun juga terbatas pada usia lanjut.
Tujuan: Mengetahui faktor-faktor prediktor mortalitas pasien pneumonia komunitas dewasa di Rumah Sakit Cipto Mangunkusumo (RSCM).
Metode: Penelitian ini merupakan studi kohort retrospektif pada pasien rawat inap dewasa RSCM yang didiagnosis pneumonia komunitas selama tahun 2010– 2014. Data klinis dan laboratorium beserta status luaran (hidup atau meninggal) selama perawatan diperoleh dari rekam medis. Analisis bivariat menggunakan uji Chi-square dilakukan pada sepuluh variabel prognostik, yakitu kelompok usia, penurunan kesadaran, komorbiditas (skor Charlson Comorbidity Index – CCI >5), sepsis, gagal napas, pneumonia berat, kadar hemoglobin <9 g/dL, hitung leukosit <4.000/ul atau >20.000/ul, kadar albumin <3 g/dL, dan kadar glukosa darah sewaktu >200 mg/dL. Data yang tidak lengkap diatasi dengan teknik multiple imputation. Variabel yang memenuhi syarat akan disertakan pada analisis multivariat dengan regresi logistik.
Hasil: Subjek penelitian terdiri dari 434 pasien. Mortalitas selama perawatan sebesar 23,9%. Sebanyak 197 (45,4%) pasien adalah laki-laki dan 237 (54,6%)pasien adalah perempuan. Median usia pasien 58 tahun (rentang 18 sampai 89)tahun dan median lama perawatan adalah 8 (rentang 1 sampai 63) hari. Patogen tersering dari hasil kultur sputum adalah Klebsiella pneumoniae (28%). Prediktor mortalitas independen yang bermakna pada analisis multivariat adalah pneumonia berat (OR=29,42; IK 95% 20,81 sampai 41,58), sepsis (OR=3,65; IK 95% 2,57 sampai 5,19), gagal napas (OR=3,2; IK 95% 1,9 sampai 5,37), skor CCI >5 (OR=2,25; IK 95% 1,6 sampai 3,15) dan kadar albumin <3 g/dL (OR=1,42; IK 95% 1,04 sampai 1,95).
Simpulan: Pneumonia berat, gagal napas, sepsis, skor CCI >5, dan kadar albumin <3 g/dL merupakan pediktor independen mortalitas pasien pneumonia komunitas dewasa saat rawat inap.

Background: Community-acquired Pneumonia (CAP) is one of the causes of death from infectious disease in the developed or developing countries. The prediction of outcome is important in decision-making process. Previous studies of predictors of mortality in overseas mostly in elderly and only found one previous study in Indonesia, but also limited in the elderly.
Objective: To determine the predictors of mortality in hospitalized patients with CAP in Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
Methods: We performed a retrospective cohort study among hospitalized patients with CAP in Cipto Mangunkusumo Hospital between 2010–2014. Data were collected at initiation of hospitalized period and the main outcome was all-cause mortality during hospitalization. We analyzed age, decreased of consciousness, comorbidity (represented as Charlson Comorbidity Index – CCI), sepsis, respiratory failure, severe pneumonia, hemoglobin level <9 g/dL, leucocyte count <4.000/ul or >20.000/ul, albumin level <9 g/dL, and blood glucose level >200 mg/dL in bivariate analysis using Chi-Square test. Missing data were handled using multiple imputation. Multivariate logistic regression analysis was performed to identify independent predictors of mortality.
Results: A total of 434 patients were evaluated in this study. In-hospital mortality rate was 23.9%. There were 197 (45,4%)male and 237 (54,6%) female patients. Median age of population was 58 (range 18 to 89) years old and median length of stay was 8 (range 1 to 63) days. The commonest pathogen was Klebsiella pneumoniae (28%). The independent predictors of mortality in multivariate analysis were severe pneumonia (OR 29.42; 95% CI 20.81 to 41.58), sepsis (OR 3.65; 95% CI 2.57 to 5.19), respiratory failure (OR 3.2; 95% CI 1.9 to 5.37), CCI score >5 (OR 2.25; 95% CI 1.6 to 3.15) and albumin level <3 g/dL (OR 1.42; 95% CI 1.04 to 1.95).
Conclusion: Severe pneumonia, respiratory failure, sepsis, CCI scores >5, and albumin level <3 g/dL were independent predictors of in-hospital mortality among hospitalized patients with CAP.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2015
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Christy Efiyanti
"Latar Belakang : Pneumonia komunitas merupakan satu masalah kesehatan yang besar. Mortalitas akibat pneumonia komunitas masih tinggi, terutama di Indonesia bila dibandingkan dengan negara-negara lain. Skor CURB-65 merupakan sistem skoring yang telah dipakai secara luas, namun memiliki beberapa kekurangan sehingga diperlukan sistem skor baru untuk menilai derajat keparahan pneumonia komunitas. Saat ini telah diperkenalkan sistem skor expanded-CURB-65 yang dinilai dapat lebih baik dalam hubungannya sebagai prediktor mortalitas 30 hari pneumonia komunitas.
Tujuan : Menilai performa kalibrasi dan diskriminasi skor expanded-CURB-65 untuk digunakan dalam memprediksi mortalitas 30 hari pasien pneumonia komunitas di Rumah Sakit Umum Pusat Nasional dr.Cipto Mangunkusumo.
Metode : Penelitian ini merupakan studi kohort prospektif dengan subyek penelitian pasien pneumonia komunitas yang datang ke IGD, poliklinik paru atau dirawat di ruang rawat RSCM. Keluaran yang dinilai adalah mortalitas pasien dalam 30 hari. Dilakukan penilaian performa diskriminasi skor expanded-CURB-65 menggunakan area under the curve AUC . Performa kalibrasi dinilai dengan plot kalibrasi dan tes Hosmer-Lemeshow.
Hasil : 267 pasien ikut serta dalam penelitian ini dengan angka mortalitas 31,5 . Performa kalibrasi ditunjukkan oleh plot kalibrasi skor expanded-CURB-65 dengan r = 0,94 serta uji Hosmer-Lemeshow dengan nilai p = 0,57. Performa diskriminasi skor expanded-CURB-65 ditunjukkan oleh kurva ROC dengan nilai AUC 0,796 IK95 0,74-0,86.
Simpulan : Mortalitas meningkat seiring peningkatan kelas risiko expanded-CURB-65. Expanded-CURB-65 menunjukkan performa kalibrasi dan diskriminasi yang baik dalam memprediksi mortalitas 30 hari pasien pneumonia komunitas di Rumah Sakit Cipto Mangunkusumo.

Background : Community acquired pneumonia is a major health problem. Mortality due to community pneumonia is still high, especially in Indonesia compared to other countries. The CURB 65 score is a widely used scoring system, but has some drawbacks so a new scoring system is needed to assess the severity of community pneumonia. Currently, the expanded CURB 65 scoring system has been assessed better to predict 30 day mortality of community acquired pneumonia.
Aim : To evaluate calibration and discrimination performance of the expanded CURB 65 score in predicting 30 days mortality of community acquired pneumonia patients at the National Center General Hospital dr.Cipto Mangunkusumo.
Method : This study was a prospective cohort study with the study subjects community acquired pneumonia patients who came to the Emergency Room ER , pulmonary polyclinics or hospitalized in RSCM. The assessed outcome was patient mortality within 30 days. Discrimination performance of the expanded CURB 65 score assessed using the area under the curve AUC . Calibration was evaluated with calibration plot and Hosmer Lemeshow test.
Results : 267 patients participated in the study with a mortality rate of 31.5. Calibration plot of expanded CURB 65 score showed r 0,94 and Hosmer Lemeshow test showed p 0,57. Discrimination was shown by ROC curve with AUC 0,796 CI95 0,74 0,86.
Conclusion : Mortality increases with increasing risk class of expanded CURB 65. Expanded CURB 65 showed a good calibration and discrimination performance in predicting 30 day mortality higher in community acquired pneumonia patients in Cipto Mangunkusumo Hospital.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2018
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Diah Adhyaksanti
"Pneumonia komunitas adalah penyebab kematian terbesar di Indonesia. Sistem skor PSI dan CURB-65 telah digunakan dalam menentukan keparahan penyakit dan keputusan tempat rawat berdasarkan risiko kematian dalam 30 hari. Tujuan penelitian ini adalah membandingkan sistem skor modifikasi PSI dan modifikasi CURB-65 pada pasien CAP sebagai prediktor mortalitas 30 hari di RS Persahabatan. Penelitian ini adalah kohort prospektif yang dilakukan pada pasien CAP yang dirawat di RS Persahabatan sejak bulan Oktober 2012-Maret 2013. Gejala klinis nilai laboratorium, foto toraks, penyakit penyerta skor PSI dan CURB-65 serta hasil akhir berupa kematian dicatat untuk dianalisis. Selama 30 hari subjek penelitian diikuti. Sebanyak 167 pasien CAP mengikuti penelitian ini didapatkan angka kematian sebesar 18,6%. Sensitivitas PSI sama dengan CURB-65 yaitu sebesar 77,4%. Spesifisitas PSI sedikit lebih tinggi dari pada CURB-65 (58,1% vs 53,7% p < 0,001). Risiko relatif mortalitas berdasarkan PSI pada kelompok risiko tinggi sebesar 3,64 kali dibandingkan kelompok risiko rendah, sedangkan risiko relatif mortalitas berdasarkan CURB-65 pada kelompok risiko tinggi sebesar 3,15 kali dibandingkan kelompok risiko rendah. Skor CURB-65 dapat dipertimbangkan sebagai prediktor mortalitas pada pasien CAP yang di rawat inap.

Community Acquired Pneumonia (CAP) is the first leading disease with the highest mortality in hospitalized patient in Indonesia. Pneumonia severity assessment systems such as the pneumonia severity index (PSI) and CURB-65 were designed to predict severity of illness and site of care base on 30-d mortality. The purpose of this study is to comparing the PSI with CURB-65 in patient admitted with CAP as predictor 30 days mortality in Persahabatan Hospital, Jakarta. This is a prospective cohort study in hospitalized community acquired pneumonia patients in Persahabatan Hospital since October 2012- Maret 2013. Clinical symptoms, laboratory findings, chest x-ray , comorbidities, score of PSI and CURB-65, 30 days mortality were recorded for analysis. Thirty days mortality outcome were recorded to analysis which score system as the best to predict 30 days mortality. One hundred and sixtty seven patients CAP were studied with an overall 30-d mortality of 18,6%. Sensitivity of PSI were simillar with CURB-65 for predicting patients who died within 30 d (77,4% ; p < 0.001). Specificity of PSI was slighty higher than CURB-65 (58,1% vs 53,7% p < 0,001). Score PSI have risk mortality 3,64 times in high risk group CAP than low risk group CAP. Score CURB-65 have risk mortality 3,15 times in high risk group CAP than low risk CAP. CURB-65 modification was considerable to predict mortality in CAP patients hospitalized.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2013
T-Pdf
UI - Tesis Membership  Universitas Indonesia Library
cover
Simanjuntak, Rohayat Bilmahdi
"Community acquired pneumonia (CAP) oleh patogen resisten obat (PRO) memiliki tingkat keparahan yang tinggi. CAP akibat PRO memerlukan terapi antibiotik spektrum luas, skor Drugs Resistance in Pneumonia (DRIP) mampu memprediksi kasus tersebut. Penggunaan skor DRIP dapat mencegah kegagalan terapi antibiotik empirik dan mempersingkat lama rawatan, untuk itu diperlukan validasi. Penelitian ini merupakan studi Cohort Retrospektif pada pasien CAP yang dirawat inap selama periode Januari 2019 hingga Juni 2020. Data diambil dari rekam medis, kegagalan antibiotik bila terdapat kematian, pindah rawat ICU dan eskalasi antibiotik. Performa skor DRIP dianalisis dengan menentukan nilai kalibrasi dan diskriminasi, uji Hosmer-Lemeshow dan Area Under Curve (AUC). Diperoleh 480 pasien yang telah memenuhi kriteria. Terdapat 331 pasien (69%) dengan skor DRIP <4 dan 149 pasien (31%) dengan skor DRIP ≥4, dengan jumlah kegagalan antibiotik sebesar 283 pasien (59%), 174 pasien (61,4%) skor DRIP <4 dan 109 pasien (38,5%) skor DRIP ≥4. Kalibrasi DRIP menggunakan uji Hosmer-Lemeshow diperoleh p-value = 0,667 (p>0,05), diskriminasi AUC pada kurva ROC diperoleh 0,651 (IK 95%; 0,601-0,700). Skor DRIP menunjukkan performa yang cukup baik dalam memprediksi kegagalan antibiotic empiric pada pasien CAP yang terinfeksi PRO. Skor DRIP tidak berhubungan dengan lama rawatan di Rumah Sakit.

Community-acquired pneumonia (CAP) caused by drug resistant pathogens (DRP) has a high level of severity. The incidence of CAP due to DRP requires broad spectrum antibiotic therapy, the Drugs Resistance in Pneumonia (DRIP) score is able to predict these cases. The use of the DRIP score can prevent antibiotic failure and minimize length of hospitalization, but validation is needed . This research is a retrospective cohort study in CAP patients who were hospitalized during the period January 2019 to June 2020. Data were taken from patient medical records, and failure of empiric antibiotics occurs when one of this criteria are found: patient mortality, ICU transfer and escalation of antibiotics as well as length of stay. Furthermore, the performance of the DRIP score was analyzed by determining the calibration and discrimination, using the Hosmer-Lemeshow test and the Area Under Curve (AUC). There were 480 patients who met the criteria. There were 331 patients (69%) with a DRIP score <4 and 149 patients (31%) with a DRIP score ≥4, with a total of 283 patients (59%) of antibiotic failures which were detailed in 174 patients (61.4%) with a DRIP score <4 and 109 patients (38.5%) DRIP score ≥4. DRIP calibration using the Hosmer-Lemeshow test obtained p-value=0.667 (p>0.05), AUC observations on the ROC curve obtained 0.651 (95% CI; 0.601-0.700). The DRIP score showed good performance in predicting failure of empiric antibiotics in infected CAP patients. PRO. The DRIP score is not related to the length of stay in the hospital."
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2022
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
Randhy Fazralimanda
"Latar Belakang: Pneumonia berat masih menjadi masalah kesehatan utama di Indonesia dan dunia. Sistem imun diketahui memiliki peranan penting dalam patogenesis pneumonia, namun tidak banyak studi yang menilai hubungan antara kadar CD4 dan CD8 darah dengan mortalitas akibat pneumonia berat pada pasien dengan status HIV negatif.
Tujuan: Mengetahui data hubungan dan nilai potong kadar CD4 dan CD8 darah dengan angka mortalitas 30 hari pada pasien pneumonia berat di RSCM.
Metode: Penelitian berdesain kohort prospektif yang dilakukan di ruang rawat intensif RSCM periode Juni-Agustus 2020. Keluaran berupa kesintasan 30 hari, nilai titik potong optimal kadar CD4 dan CD8 darah untuk memprediksi mortalitas 30 hari dan risiko kematian. Analisis data menggunakan analisis kesintasan Kaplan-Meier, kurva ROC dan multivariat regresi Cox.
Hasil: Dari 126 subjek, terdapat 1 subjek yang loss to follow up. Mortalitas 30 hari didapatkan 26,4%. Nilai titik potong optimal kadar CD4 darah 406 sel/μL (AUC 0,651, p=0,01, sensitivitas 64%, spesifisitas 61%) dan kadar CD8 darah 263 sel/μL (AUC 0,639, p=0,018, sensitivitas 62%, spesifisitas 58%). Kadar CD4 darah < 406 sel/μL memiliki crude HR 2,696 (IK 95% 1,298-5,603) dan kadar CD8 darah < 263 sel/μL memiliki crude HR 2,133 (IK 95% 1,035-4,392) dengan adjusted HR 2,721 (IK 95% 1,343-5,512). Bila sepsis dan tuberkulosis paru ditambahkan dengan kadar CD4 darah dan CD8 darah, didapatkan nilai AUC 0,752 (p=0,000).
Kesimpulan: Kadar CD4 dan CD8 darah memiliki akurasi yang lemah dalam memprediksi mortalitas 30 hari pasien pneumonia berat. Kadar CD4 darah < 406 sel/μL dan kadar CD8 darah < 263 sel/μL memiliki risiko mortalitas 30 hari yang lebih tinggi.

Background: Severe pneumonia is a major health problem in Indonesia and the world. The immune system is known to play an important role in the pathogenesis of pneumonia, but few studies have assessed the relationship between blood CD4 and CD8 count and mortality from severe pneumonia in patients with negative HIV status.
Objectives: Knowing the correlation data and the cut-off value of blood CD4 and CD8 count with a 30-days mortality rate in severe pneumonia patients at RSCM. Methods. This study is a prospective cohort study conducted at RSCM intensive care rooms from June to August 2020. The outputs were 30-days survival rate, optimal cut-off value for blood CD4 and CD8 count to predict 30-days mortality and mortality risk. Data analysis used Kaplan-Meier survival, ROC curves and multivariate Cox regression analysis.
Results: Of the 126 subjects, there was 1 subject who lost to follow up. The 30- days mortality rate was 26.4%. The optimal cut-off value for blood CD4 count was 406 cells/μL (AUC 0.651, p=0.01, sensitivity 64%, specificity 61%), blood CD8 count was 263 cells/μL (AUC 0.639, p=0.018, sensitivity 62%, specificity 58%). CD4 blood count < 406 cells/μL had a crude HR of 2.696 (95% CI 1.298- 5.603) and blood CD8 count < 263 cells/μL had a crude HR of 2.133 (95% CI 1.035-4.392) with an adjusted HR of 2.721 (CI 95% 1,343-5,512). If sepsis and pulmonary tuberculosis were added to the blood CD4 and CD8 count, the AUC value was 0.752 (p=0.000).
Conclusion: Blood CD4 and CD8 count had poor accuracy in predicting 30-days mortality in patients with severe pneumonia. The group with blood CD4 count < 406 cells/μL and blood CD8 count < 263 cells/μL had a higher risk of 30-days mortality.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2020
SP-pdf
UI - Tugas Akhir  Universitas Indonesia Library
cover
"Pneumonia is one of very important global health problems among toddlers, especially in developing countries. Nowadays, pneumonia is one of largest causes of child mortality, especially in newborn period. In Aceh Province, pneumonia disease is the eighth of 25 biggest diseases found at primary health care with 112 cases, while pneumonia among outpatient sufferers in Aceh reached 434 cases (29.03%).This study aimed to determine factors related to incidence of pneumonia toddlers in Lambatee Village, Darul Kamal Subdistrict, Aceh Besar District.
This study was analytical descriptive using cross-sectional design. Samples of study were mothers and toddlers amounted to 48 people. Data were collected on August 3rd - 14th, 2015 by interview, observation. Multivariate analysis used logistic regression. Results of study showed that the factor physical condition of house sanitation influenced to trend among toddlers suffering from pneumonia with p value 0.01< 0.05, the highest OR score 6.431 and 95% CI = 1.559 - 26.532. In conclusion, physical condition of house sanitation had six times risk of causing trend of pneumonia incidence among toddlers in Lambatee Village, Darul Kamal Subdistrict, Aceh Besar District."
Aceh health polytechnic ministry of health, aceh, indonesia, 2016
AJ-Pdf
Artikel Jurnal  Universitas Indonesia Library
<<   1 2 3 4 5 6 7 8 9 10   >>